Three publications this week:
- Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations | link
- Dying to Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era | link
- Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.